0709 203000 - Nairobi 0709 983000 - Kilifi
0709 203000 - NRB 0709 983000 - Kilifi
0709 203000 - NRB | 0709 983000 - Kilifi

Back Home

Isabella Ochola-Oyier/BMC Infect Dis


4 results

Pre-COVID-19 ex vivo cross-reactive IFN-gamma cellular response to SARS-CoV-2 spike overlapping peptides is more prevalent among Kenyan compared to Swedish adults.Wanjiku, P. Orindi, B. Mwacharo, J. Chemweno, J. Karanja, H. K. Kronsteiner, B. Kai, O. Wright, D. Ochola-Oyier, L. I. Sundling, C. Dunachie, S. Warimwe, G. M. Farnert, A. Bejon, P. Ndungu, F. M. Nduati, E. W.
BMC Infect Dis, (2026). 26:174

Detection of low frequency artemisinin resistance mutations, C469Y, P553L and A675V, and fixed antifolate resistance mutations in asymptomatic primary school children in Kenya.Osoti, V. Wamae, K. Ndwiga, L. Gichuki, P. M. Okoyo, C. Kepha, S. Keitany, K. Kandie, R. Aricha, S. Kiplagat, R. Mwandawiro, C. Bejon, P. Snow, R. W. Ochola-Oyier, L. I.
BMC Infect Dis, (2025). 25:73

Evaluation of population immunity against SARS-CoV-2 variants, EG.5.1, FY.4, BA.2.86, JN.1, JN.1.4, and KP.3.1.1 using samples from two health demographic surveillance systems in Kenya.Lugano, D. Kutima, B. Kimani, M. Sigilai, A. Gitonga, J. Karani, A. Akech, D. Karia, B. Ziraba, A. K. Maina, A. Lambisia, A. Omuoyo, D. Mugo, D. Lucinde, R. Owuor, S. Konyino, G. Newman, J. Bailey, D. Nduati, E. Githinji, G. Agoti, C. N. Bejon, P. Scott, J. A. G. Agweyu, A. Kagucia, W. Warimwe, G. M. Sande, C. Ochola-Oyier, L. I. Nyagwange, J.
BMC Infect Dis, (2024). 24:1474

Distinct transcriptomic signatures define febrile malaria depending on initial infective states, asymptomatic or uninfected.Kimenyi, K. M. Akinyi, M. Y. Mwikali, K. Gilmore, T. Mwangi, S. Omer, E. Gichuki, B. Wambua, J. Njunge, J. Obiero, G. Bejon, P. Langhorne, J. Abdi, A. Ochola-Oyier, L. I.
BMC Infect Dis, (2024). 24:140